You think once we get a partner that IPIX will have any further word in financing and directing the clinical trials for those indications partnered? That would be the tail wagging the dog big time. BP has all the technical assets as to lab and personnel so why would they ever consider leaving such matters to a startup of 7 employees? Ridiculous IMO.